In recent months, the world has been grappling with a new strain of coronavirus that has caused widespread illness and death. While the symptoms of COVID-19 are well-known, there have been reports of variant symptoms and differences in severity among those who contract the virus.
One study published in The Lancet Infectious Diseases found that people infected with the B.1.1.7 variant, first identified in the UK, were more likely to experience coughing, sore throat, fatigue and muscle aches than those with earlier strains of the virus. However, they were less likely to report loss of taste or smell.
Another study conducted by researchers at King’s College London found that patients infected with the B.1.617 variant first identified in India were more likely to suffer from severe disease requiring hospitalization compared to those infected with other variants.
These findings highlight how important it is for healthcare professionals to remain vigilant when it comes to identifying new symptoms or changes in disease severity related to COVID-19 as new variants emerge.
It also underscores the importance of continued efforts towards vaccination against COVID-19 worldwide as evidence suggests that vaccines currently available do provide protection against these variants despite their different symptom profiles and severities.
Overall, while much remains unknown about these new variants and their potential impact on public health outcomes globally; continued research will help us better understand how we can contain its spread and limit its impact on populations vulnerable to severe disease outcomes such as elderly individuals or immunocompromised persons who may be at higher risk given these emerging trends concerning differing symptom profiles observed so far among individuals affected by them compared to earlier strains circulating before their emergence on a wider scale beyond few countries where they were initially detected .